BRIEF published on 07/01/2026 at 18:05, 2 months 9 days ago Information on the shares and voting rights of EuroLand Corporate Voting Rights Actions Paris Euronext Growth EuroLand Corporate
PRESS RELEASE published on 07/01/2026 at 18:00, 2 months 9 days ago Information relative aux actions et droits de vote EUROLAND CORPORATE, société cotée sur Euronext Growth Paris, communique les chiffres clés de ses droits de vote pour le 30 juin 2026 Euronext Growth Paris Droits De Vote EuroLand Corporate 30 Juin 2026
BRIEF published on 06/03/2026 at 18:05, 3 months 7 days ago EUROLAND CORPORATE: Information on shares and voting rights Exercisable Voting Rights Euronext Growth Shares And Voting Rights EuroLand Corporate May 31, 2026
BRIEF published on 06/03/2026 at 18:05, 3 months 7 days ago EUROLAND CORPORATE : Informations sur les actions et droits de vote Euronext Growth EuroLand Corporate Actions Et Droits De Vote Droits De Vote Exerçables 31 Mai 2026
PRESS RELEASE published on 06/03/2026 at 18:00, 3 months 7 days ago Information relative aux actions et droits de vote EuroLand Corporate, société cotée sur Euronext Growth Paris, annonce les chiffres de ses droits de vote. Consultez le site web pour plus d'informations Euronext Growth Paris Investissement Droits De Vote ISIN EuroLand Corporate
BRIEF published on 05/04/2026 at 18:05, 4 months 6 days ago EuroLand Corporate's shares and voting rights as of April 30, 2026 Voting Rights Actions Paris Euronext Growth EuroLand Corporate
BRIEF published on 05/04/2026 at 18:05, 4 months 6 days ago Les actions et droits de vote d'EuroLand Corporate au 30 avril 2026 Droits De Vote Actions Paris Euronext Growth EuroLand Corporate
PRESS RELEASE published on 05/04/2026 at 18:00, 4 months 6 days ago Information relative aux actions et droits de vote EUROLAND CORPORATE communique les informations sur son capital et ses droits de vote au 30 avril 2026. Retrouvez-les ici Euronext Growth Paris Capital Droits De Vote EuroLand Corporate 30 Avril 2026
BRIEF published on 04/03/2026 at 17:50, 5 months 7 days ago État des Actions et Droits de Vote chez EuroLand Corporate Marché Financier Droits De Vote Actions Euronext Growth EuroLand Corporate
BRIEF published on 04/03/2026 at 17:50, 5 months 7 days ago Status of Shares and Voting Rights at EuroLand Corporate Voting Rights Actions Euronext Growth Financial Market EuroLand Corporate
Published on 09/11/2026 at 04:00, 5 hours 35 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 10 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 15 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 35 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 15 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 29 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 35 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 35 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 35 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 35 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 5 minutes ago Availability of the 2026 Interim Financial Report
